Literature DB >> 22042925

Ineffective therapy, underpowered studies, or merely too little, too late? Risk factors and impact of maternal corticosteroid treatment on outcome in antibody-associated fetal heart block.

Jodi I Pike, Mary T Donofrio, Charles I Berul.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22042925     DOI： 10.1161/CIRCULATIONAHA.111.061267

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  3 in total

1.  Maternal use of hydroxychloroquine is associated with a reduced risk of recurrent anti-SSA/Ro-antibody-associated cardiac manifestations of neonatal lupus.

Authors:  Peter M Izmirly; Nathalie Costedoat-Chalumeau; Cecilia N Pisoni; Munther A Khamashta; Mimi Y Kim; Amit Saxena; Deborah Friedman; Carolina Llanos; Jean-Charles Piette; Jill P Buyon
Journal:  Circulation       Date:  2012-05-24       Impact factor: 29.690

Review 2.  Autoimmune-associated Congenital Heart Block: A New Insight in Fetal Life.

Authors:  Kai-Yu Zhou; Yi-Min Hua
Journal:  Chin Med J (Engl)       Date:  2017-12-05       Impact factor: 2.628

3.  Two case reports of neonatal autoantibody-associated congenital heart block.

Authors:  Xiaoxia Li; Xianmei Huang; Hui Lu
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.889
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.